Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 5
1995 46
1996 125
1997 228
1998 241
1999 259
2000 279
2001 250
2002 251
2003 289
2004 252
2005 301
2006 248
2007 248
2008 236
2009 260
2010 226
2011 201
2012 230
2013 188
2014 207
2015 148
2016 137
2017 125
2018 99
2019 116
2020 76
Text availability
Article attribute
Article type
Publication date

Search Results

4,886 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and management of factor V Leiden.
Campello E, Spiezia L, Simioni P. Campello E, et al. Expert Rev Hematol. 2016 Dec;9(12):1139-1149. doi: 10.1080/17474086.2016.1249364. Epub 2016 Oct 31. Expert Rev Hematol. 2016. PMID: 27797270 Review.
The discovery of the factor V Leiden (FVL) missense mutation (Arg506Gln) causing factor V resistance to the anticoagulant action of activated protein C was a landmark that allowed a better understanding of the basis of inherited thrombotic risk. …
The discovery of the factor V Leiden (FVL) missense mutation (Arg506Gln) causing factor V resistance to t …
Factor V Leiden.
Applegate JS, Gronefeld D. Applegate JS, et al. Radiol Technol. 2019 Jan;90(3):259-273. Radiol Technol. 2019. PMID: 30635457 Review.
Factor V Leiden thrombophilia is a genetic mutation that results in hypercoagulation of the blood that presents life-threatening symptoms. This article describes the role of imaging in diagnosis and treatment of cardiovascular complications caused by facto
Factor V Leiden thrombophilia is a genetic mutation that results in hypercoagulation of the blood that presents life-th
Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
Beye A, Pindur G. Beye A, et al. Clin Hemorheol Microcirc. 2017;67(3-4):261-266. doi: 10.3233/CH-179207. Clin Hemorheol Microcirc. 2017. PMID: 28869458
Gene mutations of factor V-1691 (factor V Leiden) and prothrombin-20210 being considered as the most common thrombophilia markers were analyzed in this study. ...We conclude from these data that thrombophilia in terms of factor V
Gene mutations of factor V-1691 (factor V Leiden) and prothrombin-20210 being considered as the most comm …
Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?
Walker ID. Walker ID. Blood Rev. 1999 Mar;13(1):8-13. doi: 10.1016/s0268-960x(99)90019-x. Blood Rev. 1999. PMID: 10225605 Review.
In Caucasian populations, factor V Leiden is very prevalent, being present in between 3 and 7% of Europeans and white North Americans. The high prevalence of the defect and its apparent interaction with combined oral contraceptive pills has led to the suggest …
In Caucasian populations, factor V Leiden is very prevalent, being present in between 3 and 7% of Europeans and white N …
The association of factor V leiden mutation with recurrent pregnancy loss.
Kashif S, Kashif MA, Saeed A. Kashif S, et al. J Pak Med Assoc. 2015 Nov;65(11):1169-72. J Pak Med Assoc. 2015. PMID: 26564286 Free article.
In order to identify Factor V Leiden mutation, polymerase chain reaction method was utilised combined with the amplification refractory mutation system. ...CONCLUSIONS: Factor V Leiden mutation, Recurrent pregnancy loss, PCR (Polymerase c …
In order to identify Factor V Leiden mutation, polymerase chain reaction method was utilised combined with the amplific …
Why is factor V Leiden so rare in the Basques?
Bauduer F. Bauduer F. J Thromb Haemost. 2015 May;13(5):697-8. doi: 10.1111/jth.12859. Epub 2015 Feb 20. J Thromb Haemost. 2015. PMID: 25645287 Free article.
Factor V Leiden is the most common inherited trait in Caucasians that predisposes individuals to venous thrombosis. However, it is almost absent amongst the Basque people that live in the south western part of Europe. ...
Factor V Leiden is the most common inherited trait in Caucasians that predisposes individuals to venous thrombosis. How
Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
Heraudeau A, Delluc A, Le Henaff M, Lacut K, Leroyer C, Desrues B, Couturaud F, Tromeur C. Heraudeau A, et al. PLoS One. 2018 May 18;13(5):e0194973. doi: 10.1371/journal.pone.0194973. eCollection 2018. PLoS One. 2018. PMID: 29775482 Free PMC article.
BACKGROUND: Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation. The impact of the …
BACKGROUND: Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critical …
Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
Gadelha T, Roldán V, Lecumberri R, Trujillo-Santos J, del Campo R, Poggio R, Monreal M; RIETE Investigators. Gadelha T, et al. Thromb Res. 2010 Oct;126(4):283-6. doi: 10.1016/j.thromres.2010.06.019. Epub 2010 Jul 13. Thromb Res. 2010. PMID: 20627204
Of these, 345 had factor V Leiden, 261 had prothrombin G20210A, and 2399 tested negative. Sixty-two percent of the VTE episodes in women with factor V Leiden or prothrombin G20210A (40% in men) were associated with an acquired risk fac
Of these, 345 had factor V Leiden, 261 had prothrombin G20210A, and 2399 tested negative. Sixty-two percent of the VTE …
Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay.
Amiral J, Vissac AM, Seghatchian J. Amiral J, et al. Transfus Apher Sci. 2017 Dec;56(6):906-913. doi: 10.1016/j.transci.2017.11.021. Epub 2017 Nov 14. Transfus Apher Sci. 2017. PMID: 29162399 Review.
Factor V-Leiden concentration is usually >75% in homozygous patients, 30-60% in heterozygous patients and below 5% in normal. ...This new assay for Factor V-Leiden can be easily used in any coagulation laboratory, is performed as a sin
Factor V-Leiden concentration is usually >75% in homozygous patients, 30-60% in heterozygous patients and below 5% i
The relationship between the levels and function of endothelial progenitor cells and factor V Leiden and protein C deficiency in patients with primary Budd-Chiari syndrome.
Guan ZY, Yu CW, Song T, Gao Y. Guan ZY, et al. Eur Rev Med Pharmacol Sci. 2018 May;22(9):2742-2750. doi: 10.26355/eurrev_201805_14971. Eur Rev Med Pharmacol Sci. 2018. PMID: 29771426 Free article.
The factor V Leiden mutation, protein C deficiency and protein S deficiency were evaluated. Finally, the relationship between the levels and function of endothelial progenitor cells and factor V Leiden and protein C deficiency in patients …
The factor V Leiden mutation, protein C deficiency and protein S deficiency were evaluated. Finally, the relationship b …
4,886 results
Jump to page
Feedback